8th Jan 2007 16:28
Amphion Innovations plc, the developer of life science and medicaltechnology businesses, announces today that it successfully closed afundraising of GBP 612,500 (before expenses) on 29th December 2006,the shares were allotted and issued on 3rd January, 2007. £ Under the terms of the placing, the Company has issued 2,450,000new ordinary shares at 25 pence per share ("the Placing Shares"). £ The net proceeds from the placing will be used to invest in newand identified opportunities. £ Application will be made for the Placing Shares to be admitted totrading on AIM. It is expected that admission will occur at 8am onFriday 12th January 2007. The Placing Shares will rank pari passu inall respects with the existing Ordinary Shares which are currentlytraded on AIM. Following admission the total number of shares in issuewill be 100,100,224. £ As part of the Placing Richard Morgan, a director of Amphion,acquired 300,000 Ordinary Shares in the Company at the placing priceof 25p per Ordinary Share. Richard Morgan is now interested in16,289,703 Ordinary Shares representing approximately 16.274 per cent.of the total number of Ordinary Shares in issue following the Placing. £ In addition, as part of the Placing, Amphion Capital Partners (arelated entity and existing shareholder) acquired 1.025m OrdinaryShares in the Company and is now interested in 8,025,000 OrdinaryShares representing 8.017 per cent. of the total number of OrdinaryShares in issue following the Placing. The shares are registered inthe name of Amphion Capital Partners. The partners in Amphion CapitalPartners are Richard Morgan, Robert Bertoldi, Richard Mansell-Jones,Anthony Henfrey and Jim Macaleer, all of whom are directors of AmphionInnovations. £ Amphion Innovations Directors' interest in Amphion CapitalPartners: \* TR.James Macaleer 29.8%Richard Morgan 13.66%Robert Bertoldi 8.54%Richard Mansell-Jones 2.03%Anthony Henfrey 1.32% Total 55.35%\* T £ About Amphion Innovations plc £ Amphion Innovations plc is listed on the AIM Exchange in Londonunder the symbol AMP. Amphion's business is the formation, financing,management and development of life sciences and technology companies,primarily in the US and UK, working in partnership with corporations,governments, universities and entrepreneurs seeking to commercializetheir intellectual property. £ On the web: www.amphionplc.com Copyright Business Wire 2007Related Shares:
AMP.L